Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 388 | 226 | 115 | 125 | 9,154 |
| Gross Profit | 388 | 226 | 115 | 125 | 9,154 |
| Operating Expenses | 35,942 | 37,267 | 44,067 | 56,071 | 44,911 |
| Operating Income | -35,553 | -37,041 | -43,952 | -55,946 | -35,757 |
| Interest Expense | 314 | 314 | 314 | 314 | 314 |
| Other Income | 1,937 | 1,820 | 3,616 | 1,797 | -1,713 |
| Pre-tax Income | -33,930 | -35,535 | -40,649 | -54,463 | -37,784 |
| Net Income Continuous | -33,930 | -35,535 | -40,649 | -54,463 | -37,784 |
| Net Income | $-33,930 | $-35,535 | $-40,649 | $-54,463 | $-37,784 |
| EPS Basic Total Ops | -1.52 | -1.61 | -1.89 | -2.43 | -1.80 |
| EPS Basic Continuous Ops | -1.52 | -1.61 | -1.89 | -2.38 | -1.82 |
| EPS Diluted Total Ops | -1.52 | -1.61 | -1.89 | -2.43 | -1.80 |
| EPS Diluted Continuous Ops | -1.52 | -1.61 | -1.89 | -2.38 | -1.82 |
| EBITDA(a) | $-25,246 | $-35,157 | $-43,959 | $-55,333 | $-34,907 |